Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vitro Biofilm Synthesis by Staphylococcus aureus03:35

In Vitro Biofilm Synthesis by Staphylococcus aureus

1.1K
In this video, we demonstrate the preparation of in vitro biofilm by S. aureus in a poly-L-Lysine-coated multi-well plate. The biofilm-formed plate can be used for downstream...
1.1K
Development and Assessment of Intracellular Infection Models for Staphylococcus aureus08:32

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

1.2K
Staphylococcus aureus (S. aureus) has the capability to disseminate throughout the body, causing persistent and recurrent infections. To better understand these processes, this study establishes an intracellular infection model for S. aureus. This model will provide a crucial foundation for investigating the mechanisms behind intracellular...
1.2K
Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR (RS-PCR)08:51

Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR (RS-PCR)

10.1K
Here, ribosomal spacer PCR (RS-PCR) is used together with a miniaturized electrophoresis system as a fast and high resolution method for genotyping S. aureus at moderate costs allowing a high...
10.1K
Cytotoxicity Assay of Staphylococcus aureus Strains on Neutrophils following Phagocytosis03:35

Cytotoxicity Assay of Staphylococcus aureus Strains on Neutrophils following Phagocytosis

542
In this video, we demonstrate an assay to detect the cytotoxicity of virulent and less virulent Staphylococcus aureus strains against human neutrophils following phagocytosis using flow...
542
Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes12:27

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

6.8K
This protocol describes a method for the purification of polymorphonuclear leukocytes from whole human blood and two distinct assays that quantify the cytotoxicity of Staphylococcus aureus against these important innate immune...
6.8K
Methodology for the Study of Horizontal Gene Transfer in Staphylococcus aureus10:39

Methodology for the Study of Horizontal Gene Transfer in Staphylococcus aureus

17.3K
We describe here three different protocols for the in vitro investigation of conjugation, transduction, and natural transformation in Staphylococcus...
17.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology and outcomes of urosepsis among admitted patients with urinary tract infections in Danish Emergency Departments: a retrospective cohort study.

Infectious diseases (London, England)·2026
Same author

Health-related quality of life in community-acquired pneumonia: a prospective cohort study.

Scientific reports·2026
Same author

Socioeconomic disparities and mortality among acute patients with sepsis: a retrospective Danish cohort study.

BMJ open·2026
Same author

Torque Teno Virus Viral Load as a Predictive Marker of Serotype-Specific Antibody Response Following the 13-Valent Conjugated Pneumococcal Vaccine in Adult Kidney Transplant Recipients: A Cohort Study.

Journal of medical virology·2026
Same author

Acute kidney injury in hospitalised patients with type 2 diabetes: Associations with continuous glucose monitoring-based glucose levels, mortality, and ICU admission.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

[Elimination of tuberculosis in Denmark].

Ugeskrift for laeger·2026

Related Experiment Video

Updated: Jan 19, 2026

In Vitro Biofilm Synthesis by Staphylococcus aureus
03:35

In Vitro Biofilm Synthesis by Staphylococcus aureus

1.1K

[Management of Staphylococcus aureus bacteraemia].

Louise Thorlacius-Ussing1, Nis Pedersen Jørgensen, Jesper Smit

  • 1louise.thorlacius-ussing@regionh.dk.

Ugeskrift for Laeger
|September 10, 2019
PubMed
Summary

Staphylococcus aureus bacteraemia (SAB) is a severe infection with limited high-quality data for diagnosis and treatment. More clinical trials are needed to develop evidence-based guidelines and improve patient outcomes for this serious condition.

More Related Videos

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
08:32

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

Published on: January 17, 2025

1.2K
Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR RS-PCR
08:51

Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR RS-PCR

Published on: November 4, 2016

10.1K

Related Experiment Videos

Last Updated: Jan 19, 2026

In Vitro Biofilm Synthesis by Staphylococcus aureus
03:35

In Vitro Biofilm Synthesis by Staphylococcus aureus

1.1K
Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
08:32

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

Published on: January 17, 2025

1.2K
Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR RS-PCR
08:51

Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR RS-PCR

Published on: November 4, 2016

10.1K

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Antimicrobial Therapy

Background:

  • Staphylococcus aureus bacteraemia (SAB) is a significant cause of severe illness, leading to high rates of morbidity and mortality.
  • Despite its clinical importance, there is a notable scarcity of high-quality data regarding the optimal diagnostic and management strategies for SAB.
  • The lack of robust evidence hinders the development of comprehensive, evidence-based guidelines for SAB treatment.

Purpose of the Study:

  • To review the current state of knowledge on Staphylococcus aureus bacteraemia (SAB).
  • To highlight the deficiencies in diagnostic and treatment data for SAB.
  • To emphasize the urgent need for controlled clinical trials to inform evidence-based guidelines.

Main Methods:

  • This is a review article, synthesizing existing literature on Staphylococcus aureus bacteraemia.
  • The review focuses on diagnostic approaches, treatment strategies, and overall patient management.
  • Key areas examined include antibiotic choice, administration route, and treatment duration.

Main Results:

  • High morbidity and mortality rates are associated with Staphylococcus aureus bacteraemia.
  • There is a significant lack of high-quality data on the diagnosis and management of SAB.
  • Evidence-based guidelines for antibiotic therapy, including drug selection, route, and duration, are currently unavailable.

Conclusions:

  • Controlled clinical trials are urgently required to address the evidence gaps in SAB management.
  • Improved evidence is crucial for developing effective, guideline-directed therapies for SAB.
  • Further research has the potential to significantly improve outcomes for patients suffering from SAB.